Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.
- DOI
- 10.1053/j.ajkd.2026.06.013
- Published
- 2026 Sep 21
- Container
- American journal of kidney diseases : the official journal of the National Kidney Foundation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1053/j.ajkd.2026.06.013,
title = {Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.},
author = {Ortega-Montiel J and Alkabbani W and Hahn G and Liu J and Byrne CF and Wexler DJ and Patorno E and Paik JM},
year = {2026},
journal = {American journal of kidney diseases : the official journal of the National Kidney Foundation},
doi = {10.1053/j.ajkd.2026.06.013},
url = {https://doi.org/10.1053/j.ajkd.2026.06.013}
}RIS
TY - JOUR TI - Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD. AU - Ortega-Montiel J AU - Alkabbani W AU - Hahn G AU - Liu J AU - Byrne CF AU - Wexler DJ AU - Patorno E AU - Paik JM PY - 2026 JO - American journal of kidney diseases : the official journal of the National Kidney Foundation DO - 10.1053/j.ajkd.2026.06.013 UR - https://doi.org/10.1053/j.ajkd.2026.06.013 ER -
APA
J, O., W, A., G, H., J, L., CF, B., DJ, W., E, P., & JM, P. (2026). Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.. American journal of kidney diseases : the official journal of the National Kidney Foundation. https://doi.org/10.1053/j.ajkd.2026.06.013
Source records
- pubmed · retrieved 2026-09-25T06:04:03.525Z